Biomarker Discovery in Lung Cancer - Malaysia
Recruiting · NCT06504927 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.
Who can take part
Age range
30 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Male or female subjects aged 30 and above.
- No previous history of any cancers.
- Able to provide X-ray and/or LDCT results.
- Have either COPD or pulmonary nodules measuring less than 11mm, or deemed not for biopsy by attending physician
- Willing to go back for a follow-up X-ray or LDCT scan in the next clinical follow up as per standard of care.
- Willing to provide up to 30mL of blood in month-0 (first visit) and up to 21mL in the next standard of care follow up visit (second visit).
Exclusion criteria
- Subject has received chemotherapy or radiotherapy for cancer treatment, and any other cancer-related treatment.
- Subject is pregnant or lactating (self-declaration).
- Subject is unwilling or unable to provide signed informed consent
Where it is running
1 location listed.
- University of Malaya Medical Centre - Kuala Lumpur, Malaysia